TVARDI THERAPEUTICS, INC. Accounts Payable
TVARDI THERAPEUTICS, INC. (TVRD) had Accounts Payable of $4.64 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $4.64M.
- 2026-03-31: Accounts Payable, Current $4.62M.
- 2025-12-31: Accounts Payable, Current $3.22M.
- 2025-09-30: Accounts Payable, Current $4.08M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.64M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.62M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $3.22M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $4.08M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.42M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.19M 10-K · filed 2026-03-31 | $1.43M 10-K · filed 2025-03-11 |
| 2024-09-30 | $2.54M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $6.75M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $4.98M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $11.58M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $7.98M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $12.12M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $4.42M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $9.60M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $15.22M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $9.74M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $5.59M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $5.63M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $5.37M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $3.39M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $4.76M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $4.89M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $6.48M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.83M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $9.31M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $9.10M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $9.54M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.48M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $4.94M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $4.37M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $2.64M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $3.69M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.16M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $3.83M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $1.19M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.86M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.69M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $4.74M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $2.39M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $2.93M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $2.35M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.97M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $1.26M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $711.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $938.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $515.00K 10-K · filed 2016-03-11 | |
| 2014-09-30 | $1.72M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.19M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.59M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $676.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |